|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Operating expenses: | |
| Research and development | |
| General and administrative | |
| Total operating expenses | |
| (Loss) income from operations | |
| Interest and other income, net | |
| Change in fair value of convertible promissory notes | |
| (Loss) income before income tax expense | |
| Income tax expense | |
| Net (loss) income | |
| Other comprehensive income: | |
| Net unrealized gain on marketable securities | |
| Comprehensive (loss) income | |
| Net (loss) income attributable to common stockholders, basic (see Note 14) | |
| Net (loss) income attributable to common stockholders, diluted (see Note 14) | |
| Net (loss) income per share attributable to common stockholders (see Note 14): | |
| Basic | |
| Diluted | |
| Weighted-average shares used in computing net (loss) income per share attributable to common stockholders (see Note 14): | |
| Basic | |
| Diluted |
Loading...
